secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longeveron Inc. (LGVN)
CIK:        0001721484
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001213900-25-106117
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Longeveron Q3 net loss $17.3M; cash runs late Q1 2026; BLA for HLHS delayed to 2027
--------------------------------------------------------------------------------

- Net loss increased 45% to $17.3M for nine months ended Sept 30, 2025 vs $11.9M in prior year.
- Revenue fell 53% to $0.8M; cash and equivalents $9.2M, funding expected only into late Q1 2026.
- Top-line results from pivotal HLHS Phase 2b trial ELPIS II expected Q3 2026, but BLA submission now anticipated in 2027.
- Completed public offering in Aug 2025 raising ~$5.0M; ATM facility of up to $10.7M available.
- Leadership: Than Powell appointed Interim CEO; Dr. Joshua Hare named Executive Chairman; Dr. George Paletta elected to board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1721484/000121390025106117/0001213900-25-106117-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1721484/000121390025106117/ea0263460-8k_longever.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-106117

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer